Mortality probabilities after revascularization and medical therapy in CAD patients under 60 years old: a

Mohammad Afrouzi1, Farbod Ebadi Fard Azar2, Ali Aboutorabi1

  • 1Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

Insights

This meta-analysis found that coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) have lower mortality rates than medical therapy (MT) in patients under 60. These findings are crucial for cost-effectiveness evaluations in coronary artery disease management.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Economics

Background:

  • Coronary artery disease (CAD) management in patients under 60 requires understanding treatment efficacy.
  • Estimating death probabilities is vital for economic evaluations of interventions like coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), and medical therapy (MT).

Purpose of the Study:

  • To estimate and compare mortality probabilities associated with CABG, PCI, and MT in patients younger than 60 years.
  • To provide data for cost-effectiveness analyses of CAD treatments in this demographic.

Main Methods:

  • Systematic literature search of PubMed, Embase, Cochrane Library, and Web of Science up to January 2021.
  • Meta-analyses conducted using Comprehensive Meta-Analysis and Review Manager.
  • Inclusion of nine studies with 16,410 patients (mean age 51.2 ± 6 years) and a mean follow-up of 3.7 ± 2 years.

Main Results:

  • Overall mortality rates after a mean follow-up were: CABG 3.6%, PCI 4.3%, and MT 9.7%.
  • In equal follow-up periods, CABG (3.5%) and PCI (4.2%) showed significantly lower mortality compared to MT (9.5%).
  • Mortality after PCI in STEMI patients was higher in the elderly versus young and lower in men versus women.

Conclusions:

  • CABG and PCI demonstrate lower mortality probabilities compared to MT in patients under 60 with CAD.
  • The estimated mortality rates are critical inputs for economic evaluations to determine the cost-effectiveness of these interventions.
  • Further analysis revealed demographic influences on PCI mortality in specific acute coronary syndrome presentations.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
67
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
43
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
81